1. SHP2 is involved in the occurrence, development and prognosis of cancer
   Shu Li et al, 2023, Oncology Letters CrossRef
2. Mometasone Furoate Inhibits the Progression of Head and Neck Squamous Cell Carcinoma via Regulating Protein Tyrosine Phosphatase Non-Receptor Type 11
   Lin Qiu et al, 2023, Biomedicines CrossRef
3. TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway
   Fen Xue et al, 2024, Journal of Gynecologic Oncology CrossRef
4. SHP2 mediates the ROS/JNK/NFAT4 signaling pathway in gastric cancer cells prompting lncRNA SNHG18 to drive gastric cancer growth and metastasis via CAR-T cells
   Lin An et al, 2024, Heliyon CrossRef
5. Dihydrotanshinone I induces necroptosis and cell cycle arrest in gastric cancer through the PTPN11/p38 pathway
   Aizhen Li et al, 2025, Toxicology in Vitro CrossRef